WAKEFIELD, Mass.--(BUSINESS WIRE)--May 25, 2006--Highlights: For the fiscal quarter ended March 31, 2006, net revenues were $140.6 million, a 40.2% increase over $100.3 million for the same period in the prior fiscal year. Net income from continuing operations for the quarter was $7.8 million, or $0.33 per diluted share, compared with $9.5 million, or $0.33 per diluted share, for the prior year period. The Company’s net income for the quarter ended March 31, 2006, was reduced by approximately $2.7 million, or $0.11 per diluted share, as a result of its Medicare Prescription Drug Program (Part D) initiative.
